| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3181797 | Actas Dermo-Sifiliográficas | 2008 | 7 Pages |
Abstract
Erlotinib induces adverse effects in most patients treated. Acneiform eruption, seborrheic dermatitis, and paronychia are the most frequently reported reactions and can lead to temporary suspension of erlotinib administration.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
G. Pitarch, J. Garde, A. Torrijos, A. Juárez, M.I. Febrer, C. Camps,